Literature DB >> 28194494

College inflammatory bowel disease (C-IBD) day: a targeted approach to shared decision-making in college age students with IBD-a 2-year pilot project.

Kofi Clarke1,2,3, Mohammad Bilal4, Heitham Abdul-Baki4,5, Paul Lebovitz4,5, Sandra El-Hachem4,5.   

Abstract

BACKGROUND: Adherence to treatment is a key therapeutic goal in chronic disorders including diabetes, inflammatory bowel disease (IBD), and hypertension. Non-adherence has been associated with increased health care costs. Previous studies have evaluated adherence to treatment in inflammatory bowel disease, as well as predictors of non-adherence. Higher belief of necessity for medications and membership of IBD patient organizations have been associated with higher medication adherence. AIM: This study aimed to identify patient reported factors that influence understanding of IBD in college age patients with IBD.
METHODS: We conducted questionnaire based survey among a group of college age patients with IBD who attended a structured program. The program consisted of a clinical appointment with an IBD physician, lecture by an IBD physician, followed by interactive segment between patients. Educational material was available for patients to review. In addition, opportunity was given to patients to share their story and ask questions in a safe environment.
RESULTS: A total of 26 patients participated in the two C-IBD sessions over a 2-year period. Twenty-three were enrolled in college, 1 was a recent graduate, and 2 were of college age but not enrolled. All patients thought the program was beneficial, 96% rated the overall experience as "awesome" or "very good." Seventy-six percent of patients reported sharing their story as the most beneficial. Only 19% found the physician lecture beneficial.
CONCLUSION: A targeted approach to a vulnerable population with IBD is an additional useful tool in improving understanding of IBD. This may lead to improved compliance with management plans.

Entities:  

Keywords:  Adherence; College age; Inflammatory bowel disease; Medication

Mesh:

Year:  2017        PMID: 28194494     DOI: 10.1007/s00384-017-2763-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  20 in total

Review 1.  Surviving chronic physical illness: psychosocial outcome in adult life.

Authors:  J Gledhill; L Rangel; E Garralda
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

2.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Authors:  A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

3.  An exploratory study of the relationship of family support and coping with adjustment: Implications for college students with a chronic illness.

Authors:  Ericka L Wodka; Lamia P Barakat
Journal:  J Adolesc       Date:  2006-05-19

Review 4.  Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review.

Authors:  C A Jackson; J Clatworthy; A Robinson; Rob Horne
Journal:  Am J Gastroenterol       Date:  2009-12-08       Impact factor: 10.864

5.  Psychological distress, social support, and disease activity in patients with inflammatory bowel disease.

Authors:  M J Sewitch; M Abrahamowicz; A Bitton; D Daly; G E Wild; A Cohen; S Katz; P L Szego; P L Dobkin
Journal:  Am J Gastroenterol       Date:  2001-05       Impact factor: 10.864

6.  Adherence to medical treatment in inflammatory bowel disease patients.

Authors:  A Zelante; A De Giorgi; R Borgoni; L Trevisani; M Gallerani
Journal:  Minerva Gastroenterol Dietol       Date:  2014-12

7.  Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease.

Authors:  J R Goodhand; N Kamperidis; B Sirwan; L Macken; N Tshuma; Y Koodun; F A Chowdhury; N M Croft; N Direkze; L Langmead; P M Irving; D S Rampton; J O Lindsay
Journal:  Aliment Pharmacol Ther       Date:  2013-09-15       Impact factor: 8.171

8.  Importance of Patients' Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease.

Authors:  Chung Hyun Tae; Sung-Ae Jung; Hye Sung Moon; Jung-A Seo; Hye Kyung Song; Chang Mo Moon; Seong-Eun Kim; Ki-Nam Shim; Hye-Kyung Jung
Journal:  J Clin Gastroenterol       Date:  2016-02       Impact factor: 3.062

Review 9.  Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review.

Authors:  Anthony Lopez; Vincent Billioud; Carina Peyrin-Biroulet; Laurent Peyrin-Biroulet
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

Review 10.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  Craig Mowat; Andrew Cole; Al Windsor; Tariq Ahmad; Ian Arnott; Richard Driscoll; Sally Mitton; Tim Orchard; Matt Rutter; Lisa Younge; Charlie Lees; Gwo-Tzer Ho; Jack Satsangi; Stuart Bloom
Journal:  Gut       Date:  2011-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.